| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 1560 |
| 1 | AMBRISENTAN | 916 |
| 2 | TADALAFIL | 907 |
| 3 | SILDENAFIL CITRATE | 888 |
| 4 | METHOTREXATE SODIUM | 792 |
| 5 | FUROSEMIDE | 717 |
| 6 | METHOTREXATE | 713 |
| 7 | PREDNISONE | 661 |
| 8 | EPOPROSTENOL | 647 |
| 9 | ACETAMINOPHEN | 566 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 647 | 0.0494 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 406 | 0.0486 |
| 2 | TEDUGLUTIDE | 516 | 0.0384 |
| 3 | SIPULEUCEL-T | 118 | 0.0203 |
| 4 | IDURSULFASE | 78 | 0.0196 |
| 5 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 142 | 0.0174 |
| 6 | LARONIDASE | 62 | 0.0150 |
| 7 | ERGOCALCIFEROL | 394 | 0.0133 |
| 8 | TREPROSTINIL | 1560 | 0.0122 |
| 9 | CLINDAMYCIN PHOSPHATE | 65 | 0.0118 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 2127 |
| 1 | Corticosteroid [EPC] | 2028 |
| 2 | Endothelin Receptor Antagonist [EPC] | 1426 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 1150 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1085 |
| 5 | Loop Diuretic [EPC] | 819 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 813 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 731 |
| 8 | Alkylating Drug [EPC] | 722 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 693 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 516 | 0.0384 |
| 1 | Interleukin-5 Antagonist [EPC] | 17 | 0.0247 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 86 | 0.0221 |
| 3 | Autologous Cellular Immunotherapy [EPC] | 118 | 0.0203 |
| 4 | Lymphocyte Growth Factor [EPC] | 25 | 0.0198 |
| 5 | Vitamin D2 Analog [EPC] | 130 | 0.0182 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 18 | 0.0166 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 214 | 0.0160 |
| 8 | Prostacycline Vasodilator [EPC] | 2127 | 0.0154 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 34 | 0.0142 |